Cargando…

An overview in the treatment of advanced ovarian cancer. MRC Gynaecological Cancer Working Party.

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971350/ https://www.ncbi.nlm.nih.gov/pubmed/2184877

Ejemplares similares

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party.
por: Hopwood, P., et al.
Publicado: (1995)

Treatment comparisons in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Publicado: (1980)

Clinico-pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. (Third report of the M.R.C. Trial, on behalf of the Working Party).
Publicado: (1984)

Recent EORTC and MRC UK studies: implications for imaging ovarian cancer
por: Spencer, John A., et al.
Publicado: (2010)

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.
por: Mead, G. M., et al.
Publicado: (1998)

Working Parties
Publicado: (2017)

MRC2020: improvements to Ximdisp and the MRC image-processing programs
por: Short, J. M., et al.
Publicado: (2023)

The role of cancer-associated fibroblast MRC-5 in pancreatic cancer
por: Ding, Song-Ming, et al.
Publicado: (2018)

The treatment of multiple myeloma--an important MRC trial.
por: Johnson, P. W., et al.
Publicado: (1994)

Oral Sessions and Working Party
Publicado: (2008)

A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party.
Publicado: (1992)

Association of benign gynaecological diseases and risk of endometrial and ovarian cancers
por: Shen, Fanghua, et al.
Publicado: (2020)

MRC2014: Extensions to the MRC format header for electron cryo-microscopy and tomography
por: Cheng, Anchi, et al.
Publicado: (2015)

Working Party on Contracts Policy
Publicado: (1968)

Report of the ISR working party
por: CERN. Geneva
Publicado: (1976)

Report of the Omicron working party
por: Allardyce, Brian W, et al.
Publicado: (1974)

Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study
por: Hall, G D, et al.
Publicado: (2004)

Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC
por: Iavazzo, Christos, et al.
Publicado: (2020)

Work-Family Life Courses and Metabolic Markers in the MRC National Survey of Health and Development
por: Lacey, Rebecca E., et al.
Publicado: (2016)

Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”
por: Manchanda, Ranjit
Publicado: (2022)

Advancement in Gynæcology
por: Westmoreland, J. G.
Publicado: (1880)

Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
por: Madi, A, et al.
Publicado: (2012)

Historical Perspectives of the Role of the MRC
por: Williams, P. O.
Publicado: (1990)

Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis
por: Gubbala, Kumar, et al.
Publicado: (2014)

Monday (after work) is party time!
por: Antonella Del Rosso
Publicado: (2013)

Report of working party on antiproton interactions
por: van Apeldoorn, G W, et al.
Publicado: (1974)

Finance Committee Working Party Memorandum
Publicado: (1958)

Working party on tests of slow extraction
por: Fidecaro, G, et al.
Publicado: (1963)

Working Party on tests of slow extraction
por: Wetherell, A M
Publicado: (1964)

Cohort differences in disease and disability in the young-old: findings from the MRC Cognitive Function and Ageing Study (MRC-CFAS)
por: Jagger, Carol, et al.
Publicado: (2007)

Sending the advance party for metastases
por: Wells, William A.
Publicado: (2006)

Gynaecologic Oncology Controversies in Cancer Treatment
por: Hunter, R.
Publicado: (1982)

2nd Birmingham gynaecological cancer workshop second line treatment of ovarian cancer - 12 May, 1988
Publicado: (1989)

Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Medical Research Council Lung Cancer Working Party.
Publicado: (1979)

Implications of an overview of chemotherapy in advanced ovarian carcinoma.
por: Williams, C. J.
Publicado: (1992)

Elevated LINC00909 Promotes Tumor Progression of Ovarian Cancer via Regulating the miR-23b-3p/MRC2 Axis
por: Yang, Xu, et al.
Publicado: (2021)

Programmme of Work of Finance Committee and Finance Committee Working Party
Publicado: (1954)

Treatment decisions in advanced ovarian cancer.
por: Cody, M. M., et al.
Publicado: (1989)

Working Party on Real-time Computer Software
por: British Iron and Steel Research. London. Plant Engineering and Energy Division
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_d0c1k9rmpcjumun712upsur8bv